Interleukin 6, Plasma
Also known as: IL6 PLA
Use
This test is primarily used to understand the pathophysiology of immune, infectious, or inflammatory disorders. It supports research attempts to elucidate the pathogenesis of such conditions. It can offer insights into the cytokine's role in various diseases, enhancing understanding and potentially guiding therapeutic decisions.
Special Instructions
Cytokine levels may exhibit diurnal variation. For accurate longitudinal comparison, it is advisable to measure cytokine levels at the same time of day.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. It is performed in a CLIA certified laboratory and is intended for clinical purposes. The performance characteristics of this test were determined by ARUP Laboratories. As the test is conducted in a research context, it may not conform to stringent regulatory approvals typically required for certain clinical diagnostics.
New York Approved
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
LOINC Codes
- 26881-3
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate plasma from cells ASAP or within 2 hours of collection.
Patient Preparation
Collect Green (lithium heparin).
Storage Instructions
CRITICAL FROZEN. Ship in ARUP Standard Transport Tube.
Causes for Rejection
Refrigerated specimens. Contaminated or heat-inactivated specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | After separation from cells: Ambient: 30 minutes |
| Refrigerated | Unacceptable |
| Frozen | 1 year |